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Existing understanding of the spatial epidemiology and
geographical distribution of Plasmodium vivax is poor.
Here we present the first systematic effort to map its
endemicity globally. Routine case reporting data were
assembled from 17,893 administrative units across the 95
P. vivax endemic countries and combined with biological
risk exclusion layers and other medical intelligence data
to update the estimated global limits of P. vivax transmis-
sion for 2010. Within areas of stable transmission, a sec-
ond assembly of 9,970 quality-checked and geopositioned
P. vivax parasite rate surveys were used with a spatiotem-
poral Bayesian model-based geostatistical approach to
estimate endemicity age-standardised to the 1-99 year
age range within every 5×5 km resolution grid square.
The model incorporated prevalence data on the refrac-
tory Duffy negativity phenotype to appropriately suppress
risk predictions, particularly in Africa. Endemicity was
predicted within a relatively narrow range of prevalence
throughout the endemic world with the point estimate
rarely exceeding 7%. These patterns are described. Radi-
cal cure of P. vivax requires treatment of the parasite’s
dormant relapsing life stages, for which primaquine is the
only drug licenced. This drug may, however, trigger mild
to severe haemolysis in patients with a genetically deter-
mined deficiency in glucose-6-phosphate dehydrogenase
production (G6PDd). We therefore also present the first
evidence-based continuous prevalence map of G6PDd
globally. Representative community surveys of phenoty-
pic G6PDd prevalence were identified for 1,734 spatially-
unique sites globally. These formed the evidence-base for
a Bayesian geostatistical model adapted to the G6PD
gene’s X-linked inheritance mechanism, which generated
a G6PDd allele frequency map across malaria endemic
countries. The resulting maps and population estimates
reflect potential risk of primaquine-associated harm.
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